Company Filing History:
Years Active: 2017
Title: Innovations by John Bernard Devine, II
Introduction
John Bernard Devine, II is an accomplished inventor based in Copley, Ohio. He has made significant contributions to the field of urology, particularly in developing devices that address urinary incontinence and retention. His innovative approach has led to the creation of a unique urinary flow control device that enhances the quality of life for many patients.
Latest Patents
Devine holds a patent for a urinary flow control device and method. This device is designed to correct urinary incontinence and urinary retention by implanting a urinary flow control device that allows for elective user control of urinary function in both male and female patients. The device functions as a mechanical valve for a natural or artificial bladder and features a longitudinally extended housing that is preferably attached to the abdominal wall. Additionally, a bladder anti-prolapse skirt may be included to repair or replace the bladder. The device provides a urine flow channel that passes through the valve, allowing the user to control the opening and closing of the valve with an external controller. The valve can be an occlusion type or a pinch type, with the flow channel functioning as an artificial urethra.
Career Highlights
Devine is associated with 3D Urologic LLC, where he continues to innovate and develop solutions for urological challenges. His work has been instrumental in advancing medical technology in this field, and he is recognized for his contributions to improving patient care.
Collaborations
Throughout his career, Devine has collaborated with notable colleagues, including Sam W. Drager and Dennis Joseph Dannemiller. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
John Bernard Devine, II is a notable inventor whose work in developing a urinary flow control device has made a significant impact in the field of urology. His dedication to improving patient outcomes through innovative solutions is commendable.